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Parachlamydia acanthamoebae and Its Zoonotic Risk
Abstract
Parachlamydia acanthamoebae has been implicated as an emerging agent of pneumonia in humans.
Recently, it has been linked to miscarriage and neonatal infections. In contrast, its role in atherosclerosis
remains controversial. In animals, there is strong evidence for Parachlamydia as a new abortigenic in
cattle, and further data on this agent in other animal species is accumulating. New diagnostic methods,
such as specific real-time PCR and immunohistochemistry with specific anti-Parachlamydia antibodies
to detect the organism within lesions, are now available to facilitate the diagnosis of parachlamydial
infections in humans and animals. This review discusses parachlamydial infections in clinical settings in
humans and animals, as well as their zoonotic potential and possible modes of transmission. Current
diagnostic tools are presented, and finally, the antibiotic susceptibility of Parachlamydia is described for
potential future preventive and therapeutic options. Nevertheless, more data on Parachlamydia and
Chlamydia-like organisms are needed to elucidate their host range and pathogenic potential in humans
and animals.
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Parachlamydia acanthamoebae has been implicated as an emerging agent of 25 
pneumonia in humans. Recently, it has been linked to miscarriage and neonatal 26 
infections. In contrast, its role in atherosclerosis remains controversial.  In animals, 27 
there is strong evidence for Parachlamydia as a new abortigenic in cattle and further 28 
data on this agent in other animal species is accumulating. New diagnostic methods 29 
such as specific real-time PCR and immunohistochemistry with specific anti-30 
Parachlamydia antibodies to detect the organism within lesions are now available to 31 
facilitate the diagnosis of parachlamydial infections in humans and animals. This review 32 
discusses parachlamydial infections in clinical settings in humans and animals as well 33 
as their zoonotic potential and possible modes of transmission. Current diagnostic tools 34 
are presented and finally, the antibiotic susceptibility of Parachlamydia is described for 35 
potential future preventive and therapeutic options. Nevertheless, more data on 36 
Parachlamydia and Chlamydia-like organisms are needed to elucidate their host range 37 
and pathogenic potential in humans and animals. 38 
 39 
Introduction 40 
Parachlamydia acanthamoebae is a gram-negative obligate intracellular bacterium 41 
belonging to the order Chlamydiales, which currently include six family-level lineage, i.e. 42 
the Chlamydiaceae, Parachlamydiaceae, Criblamydiaceae, Simkaniaceae, 43 
Rhabdochlamydiaceae and Waddliaceae (1-5).  Bacteria of the Chlamydiaceae family 44 
include well established animal and human pathogens of worldwide distribution and of 45 
high clinical importance. Chlamydiaceae are characterized by their particular 46 
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developmental cycle including elementary, intermediate and reticulate bodies taking 47 
place in eukaryotic hosts.   Parachlamydiaceae developmental cycle is characterized by 48 
elementary and reticulate bodies comparable to the one of Chlamydiaceae and a third 49 
stage, the crescent body (Figure 1D) (6). P. acanthamoebae is naturally infecting free-50 
living amoebae (Figure 1A) and may also enter and marginally replicate within 51 
pneumocytes and lung fibroblasts (7). The Parachlamydiaceae family includes other 52 
genus, species and species-level lineages (Table 1). However, this review will mainly 53 
focus on P. acanthamoebae, which has been more studied and for which there are 54 
some evidence for a pathogenic role towards animals and humans and for a zoonotic 55 
risk.  56 
 57 
Parachlamydia in ruminants 58 
Chlamydia causes abortion in large and small ruminants leading to significant economic 59 
losses worldwide (8). The typical chlamydial abortion in ruminants is caused by 60 
Chlamydophila abortus and around 20% of the sheep population in Switzerland is 61 
infected with C. abortus (9). Chlamydial abortion in cattle seems to be much less 62 
frequent compared to the situation in sheep and goat indicating species-specific 63 
differences (10). Despite comprehensive laboratory investigations, up to 70% of cattle 64 
abortion cases remain without an etiological diagnosis (11) suggesting the possible 65 
presence of new yet undescribed abortigenic agents. In 1986, Waddlia chondrophila 66 
type strain WSU 86-1044 was implicacted as a new abortigenic agent in cattle, when it 67 
was isolated in lung, liver and other tissues of an aborted fetus in the USA (12,13). A 68 
second report described the same agent in a bovine abortion co-infected with Neospora 69 
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caninum (14), but could not clarify if abortion was caused by the former or the latter 70 
agent. Further reports of W. chondrophila associated to ruminant abortion are still 71 
lacking. Studies ongoing in the authors’s laboratory focusing on ruminant abortion did 72 
not show evidence of Waddlia by specific real-time PCR or immunohistochemistry. 73 
A previous study focusing on bovine chlamydial abortion (due to C. abortus) in the 74 
eastern part of Switzerland where chlamydial abortion in small ruminants is endemic (9), 75 
found C. abortus in only 4% of late-term abortion (10). In contrast, 18.3% of cases were 76 
positive for Chlamydia-like organisms by broad-range 16S rRNA PCR. Sequencing of 77 
PCR products surprisingly revealed no similarities to W. chondrophila but to P. 78 
acanthamoebae resulting in the first PCR-based detection of this organism in a bovine 79 
abortion. To confirm these preliminary findings, a follow-up study was initiated and 80 
demonstrated the presence of Parachlamydia in bovine placenta by 81 
immunhistochemical protocols using a specific anti-Parachlamydia antibody and by 82 
transmission electron microscopy (15). In 70% of abortion cases with amplification of 83 
Chlamydia-like organisms DNA, the presence of Parachlamydia could be further 84 
confirmed by positive immunohistochemistry demonstrating the infectious agent within 85 
the placental lesions (15). The development of more specific new molecular methods 86 
such as a Parachlamydia-specific real-time PCR (16) and further improvement of the 87 
Parachlamydia-specific immunohistochemistry (15) using mouse polyclonal antibodies 88 
(17) enabled a comprehensive investigation on retrospectively collected bovine abortion 89 
cases (18). Placenta samples from late-term abortion cases in cattle were investigated 90 
by real-time PCR diagnostic for Chlamydiaceae and Parachlamydia spp., respectively 91 
and histological sections of cases positive by real-time PCR were further examined by 92 
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immunohistochemistry to demonstrate the agent within the placental lesion. 93 
Parachlamydial DNA was detected in 18.3% of cases and of these 81.4% was 94 
confirmed by immunohistochemistry. By immunohistochemistry, parachlamydial antigen 95 
was localized mainly intracytoplasmic within trophoblastic epithelium of the placenta 96 
(Figure 2D). The main histopathological feature in these parachlamydial abortion cases 97 
was purulent to necrotizing placentitis (Figure 1B). Severe placentitis will result in 98 
placental insufficiency and consecutive abortion. Presence of parachlamydial antigen 99 
within necrotic and inflamed placental tissue as demonstrated by immunohistochemistry 100 
could link placental damage to the bacteria. Although final proof is lacking by 101 
experimental infection in pregnant animals, there is strong evidence that Parachlamydia 102 
might represent a new abortigenic agent in cattle.  103 
Similar data were obtained in small ruminant abortion when placenta and fetal tissue 104 
from 211 abortion cases of goat and sheep were investigated (19). Thus, 26.1% of 105 
abortion cases were positive for C. abortus whereas only 2 cases (0.9%) were positive 106 
for Parachlamydia by real-time PCR immunohistochemistry. In both cases, necrotizing 107 
placentitis was present and interestingly, in one case fetal organs were available 108 
showing interstitial pneumonia and mixed cellular periportal hepatitis. Parachlamydia 109 
could be further detected in the fetal lung by PCR and immunohistochemistry. Mixed 110 
infection with C. abortus and Parachlamydia was present in this case and simultaneous 111 
presence of both agents could be demonstrated in the necrotic trophoblastic epithelium 112 
neutrophilic exsudate of the placenta (19). 113 
By 16S rRNA PCR, DNA of Chlamydia-like organisms was detected in semen samples 114 
of bulls and rams (20). The presence of these organims suggests the possibility of 115 
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venereal transmission of Parachlamydia and of other members of this highly diverse 116 
group of emerging pathogens. 117 
 118 
Parachlamydia in other animals 119 
Reptiles 120 
A retrospective study on reptile tissues with granulomatous inflammation focused on the 121 
presence of mycobacteria and chlamydiae. By 16S rRNA PCR, in 54.4% of cases DNA 122 
of Chlamydia-like organisms with variable sequence similarity (88-97%) to P. 123 
acanthamoebae and Simkania negevensis was detected in chelonians, lizards and 124 
snakes from zoo, shops and privat owners (21). At that time, specific antibodies for 125 
Parachlamydia were not available and samples are no more available. Thus, 126 
demonstration of the infectious agent within the granulomatous lesions was not possible 127 
and it remains unknown if Chlamydia-like organisms are involved in granuloma 128 
formation in reptiles.  129 
 130 
Swine 131 
Cervical swabs and genital tracts of sows were examined in a recent study on the 132 
diagnostic investigation into the role of chlamydiae in cases of increased rates of return 133 
to estrus in pigs (22). By broad-range 16S rRNA PCR amplifying short-length 134 
fragments, DNA of Chlamydia-like organisms were detected in 28.2% on the swabs 135 
from sows with and 22.0% of sows without reproductive problems, respectively 136 
(p>0.05). Although there was no significant difference between the two groups, the high 137 
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prevalence of Chlamydia-like organisms in cervical swabs, uteri, oviducts and tissues of 138 
aborted fetuses was unexpected.  139 
By the same method, DNA of Chlamydia-like organisms was detected in semen of 140 
boars (23). However, the significance of this finding related to reproductive disorders in 141 
boars and sows remains to be elucidated.  142 
 143 
Other mammals 144 
An association of ocular diseases in cats, koalas, guinea pigs, pigs and sheep with 145 
Chlamydia-like organisms was reported as DNA of these bacteria was amplified by PCR 146 
(24-29). However, the pathogenicity of these organisms remains unclear and need 147 
further investigation.  148 
 149 
Parachlamydia in humans 150 
Respiratory Infections 151 
P. acanthamoebae is considered as an emerging agent of pneumonia in humans 152 
(recently reviewed by Greub, 2009) (5). The first association was provided by recovery 153 
of P. acanthamoebae strain Hall’s coccus from the water of a humidifier associated with 154 
an outbreak of fever (30). Then, serological and/or molecular evidence further 155 
supported the role of Parachlamydia in bronchitis (31), community-acquired pneumonia 156 
(32), aspiration pneumonia (33) and bronchiolitis (16). The source of infection (i.e 157 
aerosolizied water, animals, or interhuman transmission) remained unidentified in all 158 
these subsequent reports. Noteworthy, some cases were identified among two 159 
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immunocompromised patients, i.e. an HIV-infected individual with low CD4 count (34) 160 
and a grafted patient (32). 161 
The possible role of Parachlamydia was further supported by its ability to remain viable 162 
for more than 2 weeks in pneumocytes (7) and by its ability to resist to destruction by 163 
human macrophages (35,36), which are in the lower respiratory tract the first line of 164 
defense of innate immunity against invading pathogens. Finally, a murine model of 165 
pneumonia caused by P. acanthamoebae was developed:  intratracheal inoculation of 166 
P. acanthamoebae induced a pneumonia in 100% of infected mice and led to a 167 
pneumonia-related mortality in 50% of them 5 days post-inoculation (37). 168 
Histopathology of the lungs was characterized by purulent pneumonia in the acute 169 
stage (2-4 das post-infection) and interstitial pneumonia in the subacute phase (7-10 170 
days post-infection) (Figure 1C). Parachlamydia could be demonstrated within the lung 171 
lesions by PCR, immunohistochemistry and electron microscopy (Figure 1D, 2C). 172 
Morever, living Parachlamydia could be recovered by amoebal co-culture fulfilling the 173 
Koch’s postulates.  174 
 175 
Miscarriage and neonatal infections 176 
P. acanthamoebae has been linked to human miscarriage and has been detected in 177 
cervical smears (38). Direct maternal-fetal transmission was documented by 178 
demonstrating the presence of parachlamydial DNA in an amniotic fluid taken from a 179 
female patient with cough and flu-like symptoms  (39). A very recent study investigated 180 
the presence of Parachlamydia in premature neonates by specific real-time PCR (40). 181 
DNA of Parachlamydia was detected in 31% of respiratory samples from 29 neonates. 182 
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Most of these patients had severe respiratory distress syndrome and the authors 183 
hypothesized that superinfection with Chlamydia-related bacteria during mechanical 184 
ventilation could have led to more severe respiratory disease. The mode of transmission 185 
of Parachlamydia could have been either (i) through a systemic infection during 186 
pregnancy, (ii) a chorio-amnionitis, or (iii) an infection at delivery by Parachlamydia 187 
colonizing the vaginal mucosa. Alternatively, infection of the newborns with 188 
Parachlamydia could have taken place during mechanical ventilation, free-living 189 
amoebae being used as carrier by these strict intracellular bacteria (41). 190 
 191 
Atherosclerosis 192 
Some reports identified a possible role of Parachlamydia in atherosclerosis. Thus, 193 
Parachlamydia DNA was amplified from abdominal aortic aneurysms and from 18.5% of 194 
aortic and carotid atherosclerotic lesions (42). A very recent study did not confirm the 195 
former results as there was neither parachlamydial DNA amplification from peripheral 196 
blood mononuclear cells nor serological evidence of anti-Parachlamydia IgG in 354 197 
patients with past history of atherosclerosis (43). Although it is difficult to definitively 198 
conclude based on these few studies, an association between atherosclerosis and 199 
Parachlamydia infection seems unlikely (43). In the past, atherosclerosis has been 200 
linked to various infectious agents but significant amount of data is mainly available for 201 
Chlamydia pneumoniae (44,45,46), which role in this setting remains nevertheless 202 
controversial.  203 
 204 
Zoonotic potential of Parachlamydia and mode of transmission 205 
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Coxiella burnettii and C. abortus are well-established infectious causes of adverse 206 
pregnancy outcomes after contact with infected ruminants (48-50). The real case 207 
numbers are probably underestimated as these agents are obligate intracellular and 208 
need special diagnostic tools. Pregnant women should thus avoid contact to sheep and 209 
goats flocks during the lambing season (48). Parachlamydia has been related 210 
repeatedly to ruminant abortion (10,15,48,49), but is also an emerging respiratory 211 
pathogen in humans (5) and has been linked to human miscarriage (38). Thus, either 212 
aerosol (comparable to transmission of C. burnettii) or oral transmission (comparable to 213 
transmission of C. abortus) of Parachlamydia from ruminant abortion material is 214 
possible and should be considered as a potential zoonotic risk. This zoonotic risk is 215 
further supported by the fact that maternal-fetal transmission of P. acanthamoebae was 216 
documented in a young woman working as a butcher in a rural area known for cattle 217 
breeding near from a small village named Bercher (Figure 3) (39). Moreover, contact to 218 
animals as infection source was clearly observed in a serological study where 3 out of 219 
482 healthy Swiss men were found positive for Parachlamydia sp., all coming from the 220 
same rural region near Lausanne (see figure 3) (51). Alternative routes of transmission 221 
are through contaminated water where free-living amoebae contain Parachlamydia or 222 
ingestion of uncooked meat or raw milk from infected ruminants.  223 
Pet animals such as dogs, cats and guinea pigs are additional sources of potential 224 
zoonotic agents. Indeed, Chlamydia-like organisms have been reported in cats (24,29) 225 
and guinea pigs with conjunctivitis (26). In the latter study, Parachlamydia-DNA was 226 
found in six symptomatic and two asymptomatic guinea pigs. Interestingly, the owner 227 
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contact lenses also harbored DNA of P. acanthamoebae suggesting a zoonotic 228 
transmission. 229 
 230 
Diagnosis of parachlamydial infections 231 
Diagnosis of parachlamydial infections is hampered by its obligate intracellular growth, 232 
by its relatively recent discovery and the very recent availability of specific diagnostic 233 
tools. Nucleic acid amplification of parachlamydial DNA was initially performed by 234 
broad-range 16S rRNA PCR (1), and by a variation of it (3) followed by sequencing. 235 
Diagnosis of well-known chlamydial infections is mostly either based on species-specific 236 
PCR tests for detection of Chlamydia trachomatis in humans or Chlamydiaceae-specific 237 
PCR methods followed by sequencing or Microarray in animals. Such PCR assays are 238 
not able to detect new Chlamydia-like organisms such as Parachlamydia. Thus, specific 239 
real-time PCR have then been developed allowing the detection of as few as 10 DNA 240 
copies of Parachlamydia in clinical samples (16,34). One of these PCRs is targeting the 241 
ADP/ATP translocase, an enzyme only present in Chlamydiae, Rickettsiae and plant 242 
plastids and absent from all other bacterial species (including those colonizing the oral 243 
cavity and potentially contaminating the lower respiratory tract samples), thus explaining 244 
the excellent specifity of the test (34). The other PCR is targeting the 16S rRNA and this 245 
will likely amplified also some other yet undiscovered species within the Parachlamydia 246 
genus (16). These PCRs have been applied to various human and animal samples.  247 
To define the possible pathogenic potential of these novel organisms, new diagnostic 248 
tool were needed to demonstrate the agent within tissue lesions. In clinical settings, 249 
samples could have been taken from a contaminated environment in the first place, i.e. 250 
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deep respiratory specimens contaminated by bacteria present in the upper airway. 251 
Thus, it is important to ensure that the infectious agent diagnosed is related to the 252 
lesion. Immunofluorescence and immunohistochemistry techniques are then the 253 
methods of choice and can be used as second confirmatory tests in addition to PCR. 254 
Mouse sera against various Chlamydia-like organisms were raised in the senior authors’ 255 
lab and the serological cross-reactivity between different Chlamydia-related organisms 256 
was determined in a preliminary study by immunofluorescence and Western Blotting 257 
(17). Subsequently, the specificity of these antisera was tested by Tissue Microarray 258 
(TMA) technology associated with immunohistochemistry on formalin-fixed and paraffin-259 
embedded pellets (52) (Figure 2A & 2B). As expected, mice antisera against P. 260 
acanthamoebae strain Hall’s coccus exhibited strong cross-reactivity to P. 261 
acanthamoebae strain BN9, but not with distantly related species (52). Antisera against 262 
P. acanthamoebae strain Hall’s coccus were then already successfully applied to 263 
formalin-fixed and paraffin-embedded bovine placenta specimens and resulted in the 264 
first report of Parachlamydia in bovine abortion (15) and follow-up studies on ruminant 265 
abortion (18,19) (Figure 2D). Rabbit anti-Parachlamydia antibodies have been applied 266 
to lung samples from mice experimentally infected with P. acanthamoebae showing 267 
good correlation with histopathological lesions and real-time PCR (27) (Figure 2C). 268 
 269 
Parachlamydia and antimicrobial susceptibility 270 
When tested in an amoebal co-culture system, Parachlamydia acanthamoebae 271 
appeared to be susceptible to macrolides and doxycycline and to be resistant to 272 
quinolones (53), exhibiting a similar susceptibility pattern than that of Waddlia 273 
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chondrophila (54). This resistance to quinolones is likely due to mutations in the 274 
quinolone-rersistance determining region of the gyrA and parC encoding genes of 275 
Parachlamydia acanthamoebae (55). Although, no animal models have confirmed these 276 
in vitro data, we thus currently recommend to use macrolides and/or doxycycline to treat 277 
infections due to any Parachlamydiaceae.  278 
 279 
Conclusion 280 
The role of P. acanthamoebae as an emerging agent of pneumonia in humans and as 281 
an abortigenic agent in ruminants has led to further study the pathogenesis of this strict 282 
intracellular bacteria and its biology, and has triggered the development of 283 
Parachlamydia-specific diagnostic tools to diagnose parachlamydial infections in 284 
humans and animals. The parallel detection of this new bacterial agent suggested a 285 
possible zoonotic risk. However, zoonotic transmission of Parachlamydia between 286 
animals and humans remains to be proven.   287 
 Persons in contact with aborted material from ruminants such as owner, animal 288 
caretakers, veterinarians should be aware of the potential zoonotic risk of well-known 289 
abortigenic agents such as C. burnettii and C. abortus, and of more recently described 290 
agents with yet poorly defined impact on human health such as P. acanthamoebae. 291 
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Figure legends 435 
Figure 1. Histopathology (Hematoxylin and eosin staining, H & E) and transmission 436 
electron microscopy in infections with Parachlamydia acanthamoebae. A. 437 
Histopathology of Acanthamoeba castellanii infected with P. acanthamoebae strain 438 
Hall’s coccus (52). Parachlamydial infection within amoebae is visible as finely 439 
basophilic stippeling. H & E staining. B. Histopathology of a bovine placenta. Purulent to 440 
necrotizing placentitis in a case of parachlamydial abortion positive by real-time PCR 441 
and immunohistochemistry for P. acanthamoebae (18). H & E staining. C. Lung 442 
histopathology of a mouse experimentally infected with living P. acanthamoebae at day 443 
7 post-inoculation (37). Interstitial pneumonia is present. H & E staining. D. 444 
Transmission electron microscopy of the lung of a mouse experimentally infected with 445 
living P. acanthamoebae and sacrificed 4 days post-infection (37). Presence of several 446 
Parachlamydia in an apoptotic cell including the crescent stage. 447 
 448 
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Figure 2. Immunohistochemistry (IHC) with mouse antiserum against Parachlamydia 449 
acanthamoebae strain Hall’s coccus. A. Uninfected Acanthamoeba castellanii. IHC with 450 
mouse antiserum against P. acanthamoebae strain Hall’s coccus (negative control). B. 451 
A. castellanii infected with P. acanthamoebae strain Hall’s coccus. IHC with mouse 452 
antiserum against Parachlamydia acanthamoebae strain Hall’s coccus (52). C. Positive 453 
IHC of the lung of a mouse infected with living Parachlamydia (37). D. IHC of a bovine 454 
placenta with the anti-Parachlamydia antibody.  Presence of positive granular reaction 455 
within trophoblastic epithelium (18). All sections were stained with the AEC/peroxidase 456 
method, hematoxylin counterstain. 457 
 458 
Figure 3. Map of Switzerland showing the location where the major outbreak of bovine 459 
abortion due to Parachlamydia acanthamoebae occurred (15) and the rural area near 460 
Bercher where a cluster of human infection due to Parachlamydia has been observed 461 
during a seroepidemiological study in young Swiss men (n=3) and during an 462 
investigation of amniotic fluids (n=1) (39,51). 463 
 464 
Table 1. Pathogenicity of Parachlamydiaceae in humans and animals  
Species     Host   Pathogenicity     References 
 
Parachlamydia acanthamoebae  Ruminants  Abortion      10,15,18,19 
      Guinea pigs  Conjunctivitis     26 
      Reptiles  Granulomatous inflammation   21 
      Mouse   Pneumonia (experimental)   37 
      Cats   Corneal disease     29 
      Humans  Community-acquired pneumonia   30,32,34 
      Humans  Aspiration pneumonia    33 
      Humans  Bronchitis      31 
      Humans  Bronchiolitis      16 
      Humans  Miscarriage, premature labor   38,39 
      Humans  Neonatal pneumonia    40 
      Humans  Arteriosclerosis     33,42,43 
      Humans  Ocular discharge     26 
 Neochlamydia hartmanellae  Cats   Conjunctivitis, keratitis    24 
Neochlamydia sp.    Fish   Gill infection      31 
Protochlamydia naegleriophila  Humans  Community-acquired pneumonia   56 
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